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1. Introduction
Quantum dot (QD) nanoparticles have 
made an indelible impression on various 
fields including chemistry, physics, and 
biomedical sciences. These nanoparticles, 
which are made up of metallic or semi-
conductor materials, typically range from 
2 to 10 nm,[1] are composed of ≈102–104 
atoms[2] and possess tunable optoelec-
tronic properties.[3] In addition, their shape 
can be precisely controlled by adjusting 
the duration, temperature, and ligand 
molecules used in their synthesis.[2b,3] 
Colloidal QDs have been widely studied 
over the past two decades both in fundamental and practical 
research, resulting in significant advances in their synthesis.[4]
The biomedical analysis should be investigated based on a 
specific and sensitive detection of target biomolecules with 
appropriate reproducibility. Fluorescence-based detection 
strategies are well-suited to meet these expectations.[5] These 
methods have been used to study biological phenomena by con-
sidering experimental parameters such as excitation, emission 
wavelength, and intensity of the fluorescent signal gener-
ated. To detect down to the single-molecule level, a number of 
eminent properties of QDs including fluorescence life-time, 
photochemical stability, fluorescence quantum yield, and 
emission anisotropy provide high resolution (nanoscale) and 
significant sensitivity.[5a]
QDs have been found as alternatives to organic and fluores-
cent dyes and are now becoming widely used in biotechnology 
and the medical field (Table 1).[6] Parameters such as highly sen-
sitive detection and practical usability can also be considered as 
important factors, which make these fluorescent nanoparticles 
desirable tools for studying biological phenomena.[7] QDs may 
be used to develop the next-generation of biological labels that 
could overcome the limitations of conventional organic dyes 
and other fluorophores.
The photophysical properties which make QDs interesting 
as compared to classic organic dyes are i) the size-tunable fluo-
rescence emission, which can be generated for any specific 
wavelength and symmetry, and ii) the broad absorption and 
narrow emission spectra, which generally makes them ideal 
for simultaneous detection of multiple fluorophores.[9] Fur-
thermore, high resistant photobleaching capabilities of QDs, in 
contrast with organic fluorophores, make these nanoparticles 
suitable candidates to be applied for continuous monitoring of 
fluorescence.[7,10] Additionally, due to the large molar extinction 
Quantum dots (QDs) with a nanoscale size range have attracted significant 
attention in various areas of nanotechnology due to their unique properties. 
Different strategies for the synthesis of QD nanoparticles are reported in which 
various factors, such as size, impurities, shape, and crystallinity, affect the QDs 
fundamental properties. Consequently, to obtain QDs with appropriate physical 
properties, it is required to select a synthesis method which allows enough 
control over the surface chemistry of QDs through fine-tuning of the synthesis 
parameters. Moreover, QDs nanocrystals are recently used in multidisciplinary 
research integrated with biological interfaces. The state-of-the-art methods for 
synthesizing QDs and bioconjugation strategies to provide insight into various 
applications of these nanomaterials are discussed herein.
Quantum Dots
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coefficients and high quantum yields of these nanoparticles, 
bright fluorescent probes are provided in aqueous solutions.[7,11] 
QD nanomaterials also have long fluorescence lifetimes 
ranging from 20 to 50 ns, which allow their signal to be sepa-
rated and distinguished from those of shorter species such as 
background or other fluorophores.[7,12] This, in turn, results in 
increased sensitivity of detection. These advantages can lead to 
their integration with nanotechnology and biology, triggering 
major advances in medical diagnostics, targeted therapeutics, 
and molecular and cellular biology.[8] Figure 1A displays a 
multicolor fluorescence micrograph obtained from a mixture 
of polymer beads containing hydrophobic QDs and spreading 
on a glass surface and Figure 1B shows CdTe QDs synthesized 
by a direct aqueous method in our lab (data not published). It 
was found that the polymer-enclosed hydrophobic QDs were 
spatially separated and did not display fluorescence resonance 
energy transfer. Modification of these polymer beads using 
biomolecular probes, such as oligonucleotides and antibodies, 
developed a biofunctionalized microstructure that exhibited 
excellent potential for molecular recognition and integrated 
codes for rapid target identification.[13]
Despite all these advantages, QDs-based detection strategies 
also impose several limitations such as high cost and the use of 
toxic materials as well as significantly larger size compared to 
organic dyes. These limitations can prevent the replacement of 
well-established dye-based tests with QD-based bioassays. The 
main limitation is that the excitation and emission wavelengths 
are dependent on the size of QDs, and even a small change in 
the size leads to significant changes in the wavelengths. Thus, 
in contrast with most organic fluorophores, the exact wave-
lengths required for excitation and emission should be empiri-
cally determined for any batch of QDs.[7]
Nevertheless, it has been demonstrated that changing the 
QD alloy composition can adjust the emission wavelengths 
while preserving the QDs size.[31] Furthermore, organic sol-
vents are used in most of the synthesis approaches where 
highly monodispersed and homogeneous QDs are produced. 
The QD nanoparticles fabricated using these techniques should 
be water soluble for biomedical purposes. Thus, surface treat-
ment and modification are inevitable steps to overcome the dif-
ficulties such as toxicity, low stability, and solubility in water.[32] 
Until now, various methods have been used for the preparation 
of QDs and these methods can be considered in different classi-
fications. In this review, we focus primarily on current synthetic 
methods for the synthesis of QDs with a brief description of 
their applications.
2. Chemical Modification Strategies
Surface modification of nanocrystals is carried out to improve the 
dispersibility of nanoparticles and reduce the aggregation and 
precipitation possibility. Moreover, changing the surface chem-
istry can be useful for further coupling of functional groups.[33] 
To apply QDs to various biomedical systems, it is important to 
provide aqueous solubility and surface modification that support 
bioconjugation. This can be achieved by attaching organic mole-
cules and macromolecules, including proteins and peptides, 
enzymes, antibodies, carbohydrate, and oligonucleotides, on 
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the surface of these nanoparticles to make them suitable for 
biomedical applications such as imaging, biosensing, and drug 
delivery systems.[8,34] Common modifications of QDs surfaces 
are illustrated in Figure 2. Depending on the final application, 
different modifications such as adding thiol groups or polyeth-
ylene glycol (PEG) on QDs can be carried out resulting in in the 
formation of nanoparticles with specific features.
In terms of QD surface modification, different strategies 
including ligand exchange, amphiphilic polymer strategy 
(encapsulation), biotin-streptavidin, silanization, etc. are used. 
For instance, for the polymer-based surface modification of 
QDs, amphiphilic polymers play a key role. Polymer-based 
modification strategies can be categorized based on a) interac-
tions of multiple side groups of polymers, as a multidentate 
compound, with the surface of nanocrystals, b) interaction of 
polymers with hydrophobic ligands of QDs, and c) polymer 
attachment to the surface of QDs via functional end groups.[35] 
Nonetheless, in the polymer-based modification, hydrophobic 
interactions between a suspended alkyl group and the native 
ligands of the nanoparticle, such as trioctylphosphine oxide 
Part. Part. Syst. Charact. 2019, 36, 1800302
Table 1. Comparison of the conventional dyes and QDs properties.
Property Conventional dyes Ref. Quantum dots Ref.
Size Approximately 0.5 nm [5a] 2–60 nm [1,15a,14]
Absorption bands The full width at half height of the maximum  
in the range of 35 nm (resonant dyes)  
to 80–100 nm (CT dyes)
[15] Wide-ranging absorption patterns: narrow emission spectra, and 
broad excitation spectra, mostly ranging from the first exciton 
absorption in the visible region toward and into the UV
[14,16]
Molar absorption  
coefficient [M−1 cm−1]
25000–250 000; at longest wavelength  
absorption maximum
[15a,17] Size dependent; 100 000–1 000 000 [18]
Fluorescence  
quantum yield
Between 0.5 and 1.0 for the visible spectrum, between 
400 and 700 nm (high fluorescence quantum yield) 
and 0.05 and 0.25 for the NIR wavelength region, 
above 700 nm (moderate fluorescence quantum yield)
[15b,17d,19] Between 0.1 and 0.8 for the visible spectrum, between 400 and 
700 nm (high fluorescence quantum yield) and 0.2 and 0.7  
for the NIR wavelength region, above 700 nm  
(high fluorescence Quantum yield)
[20]
Solubilization Solubility can be significantly increased using  
sulfonates or other charged groups; steric effects 
should be avoided by regulation of sulfonation rates
[21] Depends on chemical surface characteristics; water solubility 
methods, such as ligand exchanging, surface silanization,  
or encapsulation, are needed.
[22]
Biofunctionalization Commercial availability of functionalized dyes,  
well-established labelling, purification, and character-
ization protocols, at least possible steric hindrance, 
some challenges about high label densities  
and fluorescence quenching issues, hydrophilicity, 
influence on biomolecule correct function
[5a,23] Limited numbers of standard approaches about biomolecules 
labelling of QDs; biofunctionalization methods are typically 
based on electrostatic conjugation, biotin-streptavidin, covalent 
cross-linking, polyhistidine tags, and ligand exchange; suffers 
from limitations such as aggregation due to nonoptimal surface 
chemistry and binding of several biomolecules to a single QD 
and biomolecule orientation difficulties
[11,24]
Stability Can be less photostable than quantum dots; often 
problematic for NIR-wavelength dyes; reactive oxygen 
species (ROS) may degrade the dyes
[15b,25] Outstanding photochemical stability compared  
with organic fluorophores (stable even after continuous  
illumination for 14 h)
[5a,6c,26]
Quantification Effectively applied for quantification in an extensive 
variety of studies
[27] QD photo brightening phenomenon may prevent quantification; 
QD blinking also can affect the results
[28]
Toxicity Can be cytotoxic; mainly dose used for studies will be 
significantly lower than the doses associated  
with toxicity;
DNA intercalators can be considered as  
the major problem
[5a,29] Can be cytotoxic, Cd2+ leaking as one of the main issues  
of cadmium based quantum dots, cytotoxic surface results  
from ligands and/or aggregation which is the most reported 
causes of QDs toxicity, cytotoxic due to the size (nanotoxicity)
[30]
Figure 1. A) Fluorescent micrograph of CdSe/ZnS QD-conjugated beads immobilized on a glass surface coated with polylysine. B) Prepared CdTe QDs 
by a direct aqueous method. Reproduced with permission.[8] Copyright 2002, Elsevier.
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(TOPO) originated from the synthesis step, result in encapsula-
tion of the QDs by polymers.[36] Modification of QDs surface 
for binding of biomolecules (proteins and peptides, oligonu-
cleotides, carbohydrate, etc.) can also be achieved with different 
strategies as summarized in Table 2.
3. Organometallic-Based Synthesis
Synthetic procedures are mostly focused on obtaining mono-
dispersed and highly luminescent nanoparticles with desirable 
surface functionalities. In the 1980s, organometallic precur-
sors were used in the solution-phase synthesis of nanocrystal-
line particles,[37] followed by the establishment of an applied 
guidance for QDs synthesis.[38] Moreover, in 1993, a well-reg-
ulated method was reported by Murray et al. for nucleation 
and growth of QDs with narrow size distribution,[39] and in the 
early 2000s, Talapin et al. and Peng et al. established a method 
based on hot injection.[40] For the organometallic synthesis of 
QDs, precursors, surfactants and solvents are required where 
surfactant molecules may also play the role of solvent.[41] As 
reported by Steigerward et al.[42] the use of suitable precursors 
is an imperative stage for QD synthesis. At the growth tempera-
ture, precursor molecules, such as organometallic compounds, 
should be quickly decomposed by the solvent to produce a 
reactive species needed for nucleation steps and nanocrystal 
growth. Dimethyl cadmium (Cd (CH3)2) is an excellent example 
of a precursor used for QD synthesis and has been utilized to 
yield CdSe,[43] TOPO, octadecene (ODE), and hexadecylamine 
organic solvents containing extended alkyl chains. Cd (CH3)2 
may also be used for preparing QDs at high temperatures due 
to its high boiling point.[44] These hydrophobic organic com-
pounds possess a critical role in the inhibition of bulk semi-
conductor formation on the QD surface by providing a reaction 
media in which interaction between these compounds and 
unsaturated metal molecules occurs. Therefore, the organic 
ligands-capped nanocrystals can be soluble only in nonpolar 
hydrophobic solvents, such as chloroform.
Two stages are involved in the synthesis of QD which 
include: i) the nucleation, where precursors at high-temper-
atures form reactive monomers, resulting in nanocrystal 
nucleation; ii) the growth of the created nuclei of the precursor 
units. To isolate the nucleation and growth of nanocrystals, the 
temperature should be precisely controlled. Generally, separa-
tion of these stages is mainly determined by different factors 
including mixture temperature, injection procedure, and the 
concentration gradient.[52] The use of high reaction tempera-
tures, ranging from 150 to 350 °C, facilitates the elimination 
of crystalline defects and enhance photoluminescence (PL) 
(Figure 3A).[53]
Moreover, surfactant molecules, including nanocrystals and 
inorganic cores, are enclosed by a monolayer of organic mole-
cules, which may lead to the formation of new materials.[2b,54] 
Surfactants used for the synthesis of QDs contain two domains 
including a nonpolar tail and a polar head group. Diffusion 
properties are affected by the nonpolar tail while binding effi-
ciency is typically influenced by the polar head group.[55] Chem-
icals with amine groups, phosphine oxides, alkyl phosphonic 
acids, alkyl phosphines, and fatty acids are examples of organic 
surfactants that determine the solubility of the nanocrystals.[41] 
In 2005, Yin et al. reported that adhesion energy, which pro-
duces a dynamic solvation, is responsible for the adhesion of 
Part. Part. Syst. Charact. 2019, 36, 1800302
Figure 2. Examples of particular surface modifications of QDs. The shell around the QDs depicts surface coating. Conjugation strategies categorize 
into hydrophobic interactions and ligand-based modification. Some ligands which can be conjugated include monodentate or bidentate thiols, such 
as mercaptopropionic acid and dihydrolipoic acid, and also imidazole and polyimidazole groups, such as polyhistidine group. Water solubility of QDs 
may be mediated by amine groups, carboxyl groups, and functionalized polyethylene glycol (PEG) which can be conjugated to the surface of the coating 
part. Some QDs bioconjugation strategies include: 1) thiol-based functionalization, 2) polyhistidine tags, and 3) coating surface modification based on 
electrostatic interactions; 4) modification based on assembly of polyhistidine to carboxyl groups of coated surface mediated by nickel; 5) bioconjugation 
based on maleimide-activated QDs; 6) active ester-based coupling strategy; 7) conjugation based on biotin-streptavidin. Adapted with permission.[36] 
Copyright 2010, Elsevier. Figure not to scale.
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surfactant molecules to the nanocrystals surfaces in growth 
medium and should be considered as one of the determinative 
factors during the growth stage.[41] In this approach, further 
chemical modification of the physical properties of nanocrystals 
can be employed to use in other prospective strategies[56] aiming 
at the synthesis of nanocrystal-biomolecule conjugations.[57] 
The synthesis procedure is typically carried out in a three-neck 
flask connected to a Schlenk line, where reactant injection 
and the temperature measurement are performed through the 
necks of the flask (Figure 3B). Nanocrystals are often prepared 
under an inert atmosphere. To initiate the synthesis of QDs, the 
organic solvent and surfactant agents are loaded into the flask 
and, following the solvation, the flask is heated to 150–300 °C 
for 10–20 min under a vacuum condition to eliminate impuri-
ties. Tellurium (Te), selenium (Se), and sulfur (S) are examples 
of elemental chalcogens, which are added to the reaction media 
in the presence of a capping agent. In this process, a complex 
is formed by dissolving the elemental chalcogens in liquid tri-
octylphosphine (TOP) or tributylphosphine.[55] When the high 
surface energy of the small particles in the colloidal system 
promotes their dissolution, redeposition of the material onto 
the larger particles enable their further growth, which is a phe-
nomenon known as Ostwald ripening. Both the nucleation 
and the growth processes have important effects on the final 
particle size and morphology. The most general technique of 
QD synthesis is based on organometallic precursors. In this 
technique, the high reaction temperature (between 150 and 
350 °C) helps the exclusion of crystalline defects and improves 
the PL properties. In addition, the size distribution of QDs pre-
pared by this process can be simply optimized through temper-
ature or reaction time.[58]
Using an organometallic strategy, surfactants in the growth 
stage of the surfactant-aided synthesis of QDs are anchored to 
the surface of nanocrystals.[59] These agents serve as the sur-
face capping ligands and can control the growth of QDs during 
synthesis to maintain the appropriate size, stabilize nanopar-
ticles, prevent the aggregation, and influence the solubility of 
nanocrystals.[60] However, synthesis methods using surfactant 
Part. Part. Syst. Charact. 2019, 36, 1800302
Table 2. Biomolecule conjugation of QDs.
Surface modification strategy Biomolecule modification group Properties References
Ligand exchange Thiols, amines, phosphines,  
carboxylic acids, and pyridines
Primary surface groups such as TOP/TOPO are replaced with functionalized biomol-
ecules, the native ligands can be also covered with other ligands such as hydrophobic 
molecules, the hydrophobic part can be resistant to hydrolysis or enzymatic degrada-
tion. However, it is difficult to control the reaction procedures; it has low quantum 
yield, low optical and colloidal stability; and variation in number of conjugated  
molecules per nanocrystal can be deemed as limitations of the proposed strategy
[24b,35,45]
Biotin-streptavidin Biotin, (strept)avidin In this strategy, ionic strengths affect the binding between streptavidin and QDs. 
Aggregation at high ionic strength; low quantum yield, and small number  
of conjugated oligonucleotide per nanocrystal are other reported limitations
[24a,46]
Silanization Depends on the modified  
surface chemistry
Crosslinkers such as tetraethyl orthosilicate (TEOS) are employed. This method has 
some distinct advantages including high stability in a salted aqueous solution  
(>100 × 10−3 m) and minimal cytotoxic effects reported in cell studies making it an 
appropriate matrix for biomedical applications. However, this method suffers from 
multiple steps of modification, small number of conjugated biomolecules such as oli-
gonucleotide per nanocrystal. Also, photoluminescence (PL) quantum efficiencies can 
be reduced significantly and aggregation is possible due to interparticle crosslinking
[47]
Amphiphilic polymer strategy Depends on the modified  
surface chemistry
Nonpolar parts of polymer and native ligands of QDs are intercalated, crosslinked 
polymers encapsulate the nanocrystals and their polar and chemically reactive end 
groups are exposed to outer surface which can be used for bioconjugation, terminating 
groups are carboxylic acid, amines, maleimide groups, etc.
[35,48]
Based on EDCa) Primary-amine group All hydrophilic QDs coated by carboxyl groups are activated by EDC, amine-function-
alized DNA can react with Maleimide activated nanocrystals. The limitations of this 
approach include low conjugation yields, aggregation due to excess amount of EDC 
used, and nonspecific and irreversible binding of DNA backbone to negatively charged 
surface of QDs
[49]
Based on SIA,b) Sulfo-SMCCc),  
and Traut’s reagentd)
Primary-amine/thiolated groups Traut’s Reagent reacts with primary amines to introduce sulfhydryl groups (thiolation), 
whereas, crosslinking reagents including SIA and SMCC react toward amino groups to 
conjugate with sulfhydryl residue in other ligands via their maleimide groups. Limita-
tions include the orientation of biomolecules such as antibodies, and instability of 
conjugates in the study medium, which may result in aggregation
[50]
Based on sulfo-LC-SPDPe) Primary-amine/thiolated groups Amino-nanocrystals can react with sulfo-SMCC to change into maleimide activated 
QDs, biomolecules with amino groups can be activated with sulfo-LC-SPDP to be thio-
lated. QDs modified with sulfo-SMCC can be conjugated with thiolated biomolecules 
such as antibodies
[51]
a)EDC: 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide; b)SIA: N-hydroxysuccinimidyl iodoacetate; c)SMCC: succinimidyl 4-(N-maleimidomethyl) cyclohexane-1-carboxylate; 
d)Traut’s Reagent: (2-iminothiolane); e)Sulfo-LC-SPDP: Sulfosuccinimidyl 6-[3′-(2-pyridyldithio)propionamido] hexanoate.
© 2019 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim1800302 (6 of 20)
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yield QDs with insulating organic ligands on the surface and 
can prevent charge transport between nanocrystals.[61] To 
overcome this drawback, these organic ligands can be easily 
changed in a procedure known as ligand exchange process. 
This exchanging of surfactants on the surface of nanocrys-
tals facilitates the development of QDs with a wide range of 
functionalities for specific applications including biomedical 
applications[41,62] (Figure 4).
In optoelectronic devices, transport of charge between nano-
particles is necessary. Therefore, the ideal ligand should exhibit 
properties such as stable colloids, high conductivity, and stable 
and facile electronic interactions.[63] Recently, the synthesis 
and characterization of CdSe QDs developed with ferrocene 
phosphine and phosphine oxide derivatives as electroactive 
ligands have been reported.[64] This study reported that the 
inorganic cores of the nanoparticles were directly conjugated 
to ferrocene phosphine or phosphine oxide derivatives by their 
phosphine-oxide functional group. The absence of an inter-
vening alkyl chain spacer minimized the electroactive moiety. 
These metallocenes were directly bound to the inorganic core 
of the nanoparticle and consequently, the distance between 
the nanoparticles and the electroactive moiety was minimized. 
Meanwhile, the tertbutyl attachment, serving as the alkyl side 
chain, provided colloidal stability (Figure 5). These materials 
were shown to be acceptable photoexcited hole conductors and 
photoredox systems.
Nevertheless, high toxicity, high cost, instability of the sub-
stances, and high reaction temperatures generally suggest 
that organometallic approaches are not ideal for the synthesis 
of QDs. Although organometallic methods have presented 
promise in fabricating higher PL quantum yield and narrow 
size distributions, research has been pushed toward more envi-
ronmentally nontoxic methods.[65]
4. Nonorganometallic-Based Synthesis
Generally, organometallic-based synthesis of QD nanocrystals 
has resulted in high-quality nanomaterials. Nonetheless, due to 
high toxicity and the use of expensive and pyrophoric materials 
as well as an explosive risk, this method still suffers from some 
serious limitations for wide-range applications.[66] For instance, 
Cd (CH3)2 which is an extremely toxic, air, and moisture sensi-
tive complex, has been employed as a precursor in this strategy. 
These limitations have been overcome by using alternative 
components such as cadmium oxide (CdO),[67] cadmium acetate 
(Cd (Ac)2),[68] and cadmium myristate.[41] For example, by using 
CdO instead of the traditional pyrophoric organometallic com-
plexes, production of high-quality CdSe/ZnSe core/shell QDs 
has been reported by Reiss et al.[69] and Li et al.[70] Furthermore, 
Qu et al.[71] have reported successful incorporation of CdO for 
the synthesis of nanocrystals, including CdSe, CdS, and CdTe.
Moreover, although conventional high-quality CdSe 
nanocrystal production was considered as a rigid method, high-
quality CdSe nanoparticles well synthesized by using one-pot 
synthesis and some organic solvents (e.g., amines and fatty 
acids).[73] For example, Flames et al.[72] reported a novel method 
for rapid synthesis (5–10 min) of monodispersed (3 nm with 
a size dispersion of 6.7%), phosphine-free, and high yield 
(80–85%) nonorganometallic CdSe nanocrystals. This method 
was based on a heterogeneous mixture of Se which was dis-
solved in ODE and directly injected into a solvent (270 °C) con-
taining CdO dispersed in cadmium carboxylate. Remarkably, 
no protective atmosphere was required during synthesis as it 
had no effects on the quality of the end product. In addition, 
the synthesis procedure could be executed on an automated 
platform, hence indicating the potential of this strategy for 
scaling up the synthesis of this type of nanoparticles. Recently, 
Part. Part. Syst. Charact. 2019, 36, 1800302
Figure 3. Nucleation and growth stages in the synthesis of monodisperse nanocrystals (the La Mer model). A) During the nanocrystals growth and by 
periodically sampling aliquots from the reaction media, nanocrystals can be isolated based on size. B) Illustration of the simple machine employed in 
the synthesis of monodisperse nanocrystals. Adapted with permission.[44a] Copyright 1993, American Chemical Society.
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synthesis of II–VI nanocrystals using a high-temperature 
strategy has been modified by using single-source precur-
sors.[74] However, purifying these precursors required further 
synthetic phases. Additionally, nanocrystals synthesized from 
single-source precursors usually show lesser luminescence 
emission and occasionally polydispersed particles (Figure 6).[75]
5. Microwave-Based Synthesis
The use of microwave electromagnetic irradiation for QDs 
production can enhance the rate, yield, and scalability. These 
advantages can originate from a phenomenon named “dielec-
tric heating,” where polar materials are heated due to the strong 
absorption of microwaves.[76] In contrast to convective heating, 
the whole volume is uniformly heated using dielectric heating. 
Consequently, thermal gradient effects are reduced, resulting in 
greater control over the size and optical properties of QDs.[77] By 
forming a traditional thermal bath where precursors or solvents 
can be directly heated, the rapid growth of nanocrystals is easily 
managed based on the polarity differences between the solvent 
and the precursor. The reaction medium components including 
precursors, passivating ligands, and solvent as well as several 
microwave factors such as temperature, time, and power have 
an important role in controlling the nucleation and growth pro-
cesses, and therefore the quality of synthesized QDs.[78]
The optical properties depend on applied temperature 
and power of microwave irradiation. For example, using a 
higher temperature typically results in larger nanoparticles, 
characterized by the generation of a solution in red color.[79] 
Chalcogenide precursors can be considered as the important 
examples of compounds used for microwave-based synthesis 
that selectively absorbs the microwave energy and enables 
instantaneous nucleation and growth of nanoparticles. Hence, 
QDs can be grown rapidly and controlled by a combination of 
reactant concentration and microwave power.[80]
Microwave irradiation has also been used for the rapid syn-
thesis of water-soluble CdTe QDs (<5 m) with high fluorescence 
quantum yields around 40–60%.[81] Furthermore, a new 
strategy has been reported for the synthesis of CdSe(S) and 
ZnSe(S) QDs.[82] Qian et al. applied 3-mercaptopropionic acid 
(MPA) as a ligand to reduce the chemical reactivity of the sur-
face of nanocrystals and to serve as the source of sulfide for 
high-temperature reactions. Furthermore, InGaP, InP, CdTe, 
Part. Part. Syst. Charact. 2019, 36, 1800302
Figure 4. Schematic illustration of ligands used for the synthesis of biocompatible nanomaterials. Generally, these ligands can be categorized into four 
groups including A) anchors, B) stabilizers, C) capping molecules, and D) the biofunctional units. Anchors act as bridges between capping agents and 
crystallite by hydrophobic interactions with primary native ligands or by directly binding to atoms of QDs surfaces. Stabilizers such as polyethylene 
glycol (PEG) prevent nonspecific adsorption as well as give hydrophilicity. Capping molecules can also be used for covalent binding of biofunctional 
molecules following ligand exchange and the biofunctional units could be used in different diagnostic, therapeutic, and smart targeting systems. 
Reproduced with permission.[62b] Copyright 2016, Nature Publishing Group.
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CdSe nanocrystals,[83] and CdSe coated with ZnS[84] have been 
successfully prepared by using a microwave heating strategy.
Recently, synthesis of water-dispersed CdSe/CdS/ZnS core/
shell/shell QDs by a simple one-pot microwave irradiation 
has been reported.[85] As shown in Figure 7, CdSe QDs were 
obtained by a microwave-assisted heating of the vessel con-
taining Se precursor and Na2SO3 for 20 min. Then CdCl2 was 
dispersed in 3-mercaptopropionic acid as a surfactant. In the 
next step, both prepared Cd and Se precursors were placed into 
a vessel and heated to 100 °C for 30 s by microwave irradia-
tion. Finally, the high-pressure air was applied to cool down the 
solution to 50 °C within 2 min to obtain CdSe QDs (emission 
wavelength at 572 nm). CdSe/CdS core/shell QDs were also 
prepared by adding the prepared CdSe core QDs to a solution 
containing Cd precursor, Na2S, and the surfactant and then it is 
heated to 100 °C for 5 min. Finally, CdSe/CdS/ZnS core/shell/
shell QDs were synthesized by adding the prepared CdSe/CdS 
QDs into a solution containing ZnCl2, N2S, and MPA. The 
mixture was then heated by microwave irradiation for 5 min at 
70 °C. In this approach, by applying microwave irradiation, the 
reaction time was reduced to 30 min and resulted in QDs with 
a high PL quantum yield and excellent photostability.
6. Microemulsion-Based Synthesis
In microemulsion-based systems, two or more immis-
cible solutions are generally stabilized by incorporating an 
amphiphilic agent, resulting in a thermodynamically stable dis-
persion.[86] Microemulsion procedures are popular approaches 
for developing QDs at room temperature. They are catego-
rized as either normal microemulsions (i.e., oil-in-water) or as 
reverse microemulsions (i.e., water-in-oil).[2a] Microemulsion 
process has been known as an effective method for control-
ling the growth of narrow size-distributed and nanodispersed 
inorganic nanoparticles. This high-quality formation is due to 
the mechanism of QD synthesis in the microemulsion proce-
dures where the newly formed clusters are efficiently stabilized 
and consequently, uncontrolled growth of the QD crystals is 
inhibited.[44b,87]
The reverse micelle procedure is currently used for the syn-
thesis of QDs, by which two immiscible liquids, such as polar 
water and nonpolar long-chain alkanes, form an emulsion.[89] 
This procedure is generally well accepted for adapting the size 
and distribution of particles. Moreover, this strategy can be 
employed for the synthesis of QDs with the same shapes as 
their nuclei. Water droplets in the nanometer range, dispersed 
in nonpolar solutions, can be produced by using surfactants.[89] 
The reverse micelle method is a process where the hydrophilic 
and hydrophobic groups on opposite ends of the surfactant 
molecules create small micelle droplets in solution. The 
hydrophilic ends are accumulated in the center where the reac-
tants are entrapped, resulting solubility in the continuous oil 
phase. The micelles are vigorously stirred to increase the rate 
at which exchanges of the entrapped reactants occur, resulting 
from dynamic collisions.[89]
Part. Part. Syst. Charact. 2019, 36, 1800302
Figure 5. Morphology and chemical composition of the CdSe QDs capped with FcPtBu2. A) Representative low-magnification transmission electron 
micrograph (TEM) images of nanoparticles capped with ferrocene derivatives including FcP(O)tBu2 with size of 3.5 nm and B) FcPtBu2 with size 
of 7–7.5 nm. C) Selected area from electron diffraction pattern (SAED) revealing broad diffuse rings as a characteristic of nanoscaled particles. This 
analysis confirms the high crystallinity and the hexagonal structure of CdSe. D) Energy dispersive X-ray (EDX) analysis of CdSe sample capped with 
FcP(O)tBu2 composite, showing traces of elements including Cd, Se, Fe, and P (size: 7–7.5 nm). Reproduced with permission.[64] Copyright 2016, 
American Chemical Society.
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Recently, CdS QDs were synthesized and stabilized in situ 
in ionic liquid reverse micelles (IL RMs).[88] Briefly, 2-hydrox-
yethylammonium formate (HO-EAF) and isooctane were 
emulsified by dioctylsulfosuccinate proliniumisopropylester 
([ProC3]AOT), as an amino acid-based surface-active IL, to 
obtain reverse micelles. Then, to prepare CdS QDs embedded 
in microemulsions, Cd(NO3)2 ⋅ 6H2O and Na2S were separately 
dissolved in HO-EAF. Subsequently, this mixture was added 
to the reverse micelles and was stirred for 12 h. This IL-QDs 
hybrid system provided excellent control over size of nanomate-
rials (3.0, 3.4, and 5.7 nm in different ratios including 0.5, 0.7, 
and 1.0, respectively, and could be used in electroluminescent 
devices due to its tunable light emission with no need for fur-
ther chemical treatment (Figure 8).[88]
The reverse micelle method has been also used to produce 
II–VI core and core/shell QDs, such as CdS,[87] ZnS/CdSe,[44b] 
CdSe/ZnSe,[91] and ZnSe.[92] Furthermore, the reverse micelle-
based synthesis of QDs has been employed to make new QD-
based barcode systems for detection of cancer biomarkers.[90] 
By mixing the micellar solutions and the sulfide containing a 
micellar solution, the encoding elements including Zn2+, Cd2+, 
and Pb2+ were merged into a single QD.
Some advantages of this fabrication method include better 
control of the size of QDs (facilitated by changing the water to 
surfactant molar ratio), a narrow distribution of size, and easy 
dispersion of the QDs. However, this method 
suffers from some limitations including low 
fluorescent yield and incorporation of impu-
rities and defects (Figure 9).
7. Lab-on-a-Chip Technology-Based 
Synthesis
One of the main challenges in nanosci-
ence and nanotechnology is the synthesis of 
colloidal nanocrystals with controlled size 
distribution. Furthermore, producing pure 
and monodisperse nanocrystals is consid-
ered to be one of the major issues for many 
nanoscale types of research.[93] Microfluidic 
systems were originally developed in the 
early 1990s and have found various applica-
tions including medical diagnosis, rapid drug 
analysis, and performing chemical reactions 
in the biotechnology, pharmaceutical, and 
chemical industries.[94]
In 2002, the use of microfluidic devices 
to prepare nanocrystals was reported for 
the first time,[95] which provided many pro-
spective advantages in terms of chemical 
and biomedical applications. These devices 
provide more control over synthesis reac-
tion, leading to the formation of monodis-
perse emulsion droplets reaction. In addi-
tion, microfluidic-based synthesis of QDs 
reduces the need for precursor materials, 
making this approach easily scalable and high 
throughput. Another important aspect of this 
approach is that the synthesis reaction of QDs is isolated from 
contact with the operator and the environment, minimizing 
potential safety issues due to exposure to toxic chemicals.[96,97]
In terms of the device platforms, both classic lithography-
based and capillary-based microfluidic systems have been 
utilized for the preparation of monodisperse droplets. For 
scaling up the production, lithography-based systems have 
great potential. On the other hand, capillary-based microfluidic 
devices have demonstrated robustness in preparing multiple 
emulsions for novel material synthesis. Further, capillary-based 
microfluidic devices have been developed for the encapsula-
tion of different materials, controlling microreactions through 
confining them, and biosensing.[98] Various types of microflu-
idic devices are utilized to inject dry powder,[99] to investigate 
fluid physics[100] and detect gases mixture.[101] However,[101b,c] 
the immense majority of efforts have been currently focused on 
continuous flow reactors.[101b,c,168–170] These reactors can be cat-
egorized into two types. In the first type, precursor molecules 
are inserted in simple capillaries, which typically possess an 
inner diameter of 100–1000 µm. Being chemically inert and 
capable of withstanding high temperatures without degrada-
tion, these capillaries are commonly made from glass and 
polytetrafluoroethylene. The reagents are added using “tribu-
tary” connections joined to other capillaries. Heat-dependent 
reactions are then started by passing the pre-determined sizes 
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Figure 6. Characterization of CdSe QDs using a one-pot synthesis method. A) Representative 
TEM image of synthesized nanoparticles. B) Size distribution histogram of the obtained QDs 
through analyzing 100 different samples with quasi-spherical shape of nanocrystals. C) The 
X-ray diffractogram (XRD) pattern which shows the synthesized QDs have the crystal structure 
of zinc blende CdSe. D) Rutherford backscattering spectrum, in which two signals can be attrib-
uted to Se and Cd. Reproduced with permission.[72] Copyright 2013, American Chemical Society.
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of the capillaries through heated oil-baths.[93] In the second 
form of microfluidic devices, a solid host or “chip” is employed 
to house the channels with widths typically in the range of 
100–1000 µm. Synthesis of high-quality QDs often requires 
high-temperature reactions, which can be achieved using glass 
or silicon chips.
Kwon et al.[102] reported a continuous microfluidic system for 
in situ production of ZnSe/ZnS core/shell QDs. In this system, 
three major sections were designed for mixing the precursor, 
ZnSe formation, and ZnS shell coating (Figure 10). For easy 
monitoring of the reaction process, plastic has been used by 
applying a nickel master stamp and microinjection method. 
As illustrated in Figure 10A, this thermoplastic microreactor 
was composed of three inlet channels connected to syringe 
pumps for pumping the precursors and one outlet channel. 
Figure 10Bi shows the dimensions of microchannels of the 
device where the reactants are combined. Also, in the zigzagged 
mixing zone, the reactants are mixed (Figure 10Bii) before 
entering into the microreactor zone where heat is applied to 
induce the synthesis reaction. In the small dimension of this 
device, the flow rate of precursor solutions determines the size 
of ZnSe/ZnS core/shell QDs with the uniformity and repro-
ducibility. Thus, QD size could be easily tuned by changing the 
flow rate (Figure 10Biii).
Furthermore, Swain et al.[103] described a strategy for the 
synthesis of CdSe by using a combinatorial synthesis system 
using computer-controlled programmable isocratic pumps 
and online detectors. In this system, various parameters of 
the process could be manipulated through the programmable 
computer software. Therefore, the desired size of QDs could 
be easily achieved, which may overcome the challenges such as 
economic viability, and efficiency of the development of QDs.
8. Direct Aqueous-Based Synthesis
Aqueous-derived QDs are appropriate for biomedical applica-
tions, and their synthesis is commonly safer, simpler, and less 
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Figure 7. Preparation and characterization of CdSe/CdS/ZnS core/shell/shell QDs. A) an illustration for the microwave-assisted synthesis of core/
shell/shell QDs. In this method, water-dispersed CdSe/CdS/ZnS core/shell/shell QDs were synthesized for each component via a simple one-
pot microwave irradiation. B) Representative transmission electron microscopy (TEM) images of i–iii) CdSe, CdSe/CdS, and CdSe/CdS/ZnS QDs, 
iv–vi) high resolution TEM (HRTEM), and vii–ix) selected area electron diffraction (SAED). Generally, prepared QDs show spherical morphology 
(3.2 nm for CdSe, 3.7 nm for CdSe/CdS, and 3.9 nm for CdSe/CdS/ZnS QDs) and HRTEM analysis reveals lattice planes which extend across the entire 
particle. Moreover, the SAED images show the same three diffraction plane rings from inner to outer, implying the similar crystal structure to that of bulk 
cubic zinc blende. C,i) UV–vis absorption and ii) photoluminescence spectra of prepared QDs. Following synthesis of CdSe QDs (excitation: 390 nm, 
emission: 575 nm), CdSe/CdS QDs was formed which shows 50 nm shifts for UV–vis absorption and 25 nm for PL spectra. By formation of CdSe/
CdS/ZnS QDs, they show 5 nm shift compared with CdSe/CdS QDs and PL intensity was increased. Reproduced with permission.[85] Copyright 2015, 
American Chemical Society.
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expensive compared to nonaqueous-derived QDs. Recently, 
the synthesis of water-based nanoscale crystals with thiol 
capping agents has become increasingly popular as an alter-
native reductant for the water-based synthesis of QDs.[104] 
This aqueous-based technique is categorized in two aspects: 
i) stronger affinity of thiol-ligands for conjugation with the sur-
face of nanocrystals compared with the affinity of trioctylphos-
phine oxide and ii) nucleation at room temperature with crystal 
growth at a higher temperature (≈100 °C).[105] Therefore, direct 
aqueous-based production of QDs can be more appropriate for 
the controlled synthesis of magic-sized clusters. Magic-sized 
clusters are intermediates in the synthesis process that are 
composed of a specific number of atoms in an arrangement 
that makes them extremely stable structures.[106] Rogach et al. 
introduced the aqueous-based synthesis of CdTe nanoparticles 
capped with thioglycerol and mercaptoethanol in 1996.[107] This 
was followed by Kapitonov and Rogach who reported successful 
synthesis of thiol-stabilized CdTe QDs and CdSe QDs by using 
NaHX, where X is Se, Te, etc. and metal salt.[108] Due to the 
good water solubility, biocompatibility, and passivation effect, 
biothiols such as cysteine have also been used as stabilizers in 
the production of II–VI semiconductor nanocrystals.[109]
Based on the classic approach for the synthesis of CdTe, a 
solution of Cd (ClO4)2 and thiol stabilizer is treated with H2Te 
gas, which is produced by the chemical decomposition of 
Al2Te3 powder by concentrated sulfuric acid. Through this pro-
cess, nonluminescent CdTe clusters are achieved, and in the 
next step nonluminescent solutions are heated under reflux at 
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Figure 8. Main properties of CdS QDs. A,B) UV–vis absorption and fluorescence emission spectra of CdS QDs embedded in reverse micelles of micro-
emulsions (excitonic band: 450 nm) at different ratios (0.5, 0.7, 1.0). C) Chromaticity coordinates for the fluorescent microemulsions, showing pinkish 
white (3.0 nm), yellowish-white (3.4 nm), and bluish white (5.7 nm) regions (in inset images), and D) transient PL decays at trap states of CdS QDs. 
Reproduced with permission.[88] Copyright 2016, American Chemical Society.
Figure 9. Illustration of reverse micelle-based QDs electrochemically encoded with Zn2+, Cd2+, and Pb2+ ions and then decoded by voltammetric strip-
ping method. Reproduced with permission.[90] Copyright 2010, American Chemical Society.
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100 °C for several h to produce CdTe QDs.[111] Extended reflux 
times lead to larger QDs, hence the size of nanocrystals can be 
adjusted by the time given for reflux. To synthesize QDs larger 
than 6 nm, the addition of a source of cadmium and stabi-
lizer, coupled with higher concentrations of H2Te are required 
(Figure 11).
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Figure 10. The principle of microfluidic-based synthesis of uniform QDs. A) An illustration of the microfluidics-based synthesis of ZnSe/ZnS core/
shell using the continuous-flow thermoplastic microfluidic platform. B) Representative scanning electron microscope (SEM) images from i) inlet and 
ii) mixing zone and iii) a photograph of the fabricated device. Reproduced with permission.[102] Copyright 2012, John Wiley & Sons, Inc.
Figure 11. Graphical illustration of water-soluble CdTe QDs synthesis. In this synthesis strategy, H2Te2, produced from the reaction between H2SO4 
and Al2Te4, forms CdTe nanocrystals through a two-step reaction. In a similar synthesis route, Selenite salts can be used instead of Telluride salts to 
produce CdSe QDs. In order to fine-tune the size of the produced QDs, the synthesis condition should be carefully optimized. Adapted with permis-
sion.[110] Copyright 1996, John Wiley & Sons, Inc.
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9. Other Synthesis Procedures
9.1. Metathesis, Thermolysis, Dehalosilylation,  
and Transmetalation Reactions
In recent years, significant progress has been made in the 
development and application of group III–V QDs. However, 
increased covalently bonded components in the structure 
of group III–V QDs results in poor crystallinity. In contrast 
to group II–VI QDs, the progress on synthesis methods of 
group III–V QDs is sluggish as a result of poor crystallinity.[112] 
Moreover, in most group III–V QDs, the growth of nanocrys-
tals required a long time (e.g., up to several days) and yielded 
particles with a broad size distribution and indistinguish-
able absorption peaks. In addition, the inherent shortcomings 
of accessible precursors have also made little improvement 
in the group III–V QD synthesis.[113] Therefore, large-scale 
production and commercialization of group III–V QDs can 
be challenging due to the lag of their synthesis techniques. 
The following reactions have been commonly considered 
for the synthesis of group III–V QDs: metathesis,[114] ther-
molysis,[115] dehalosilylation,[113a,116] and transmetalation.[117] 
Metathesis reaction, also known as double displacement reac-
tion, is a chemical transformation in which the chemical bonds 
are exchanged between the reactants, yielding products with 
similar or identical bond types.[114] In preparation of group 
III–V QDs, group III–V bonds could be established from Ga- or 
In-halides as III-based precursors and from alkali nitrides or 
arsenides as V-based precursors.[118] Reaction systems involving 
metathesis or single source precursors generally require high 
temperatures (>400 °C) or several days to complete the reac-
tion. In addition, it is difficult to control the sizes of QDs 
synthesized using metathesis, which results in polydispersed 
nanocrystals.[114b]
Thermolysis is a type of endothermic reaction in which the 
decomposition of a single or dual source material is triggered 
by heat. In most cases, for the synthesis of group III–V QDs, 
reactions are conducted by thermally decomposing pre-synthe-
sized solid-state complexes containing both III and V precur-
sors.[115] Additionally, to obtain monodispersed group III–V 
nanocrystals, reactions are transferred into a solvent with a high 
boiling point to meet the requirement of high temperature.[119]
The dehalosilylation reaction, which is also referred to as 
trimethylhalosilane elimination, was introduced by Wells et al. 
and has been extensively investigated through the removal of 
various ligands to obtain the group III–V QDs.[120] In this way, 
group-III halides and group-V organometallic precursors, such 
as tris(trimethylsilyl)arsine [As(TMSi)3] or tris(trimethylsilyl)
phosphine [P(TMS)3], were utilized in a coordinating solvent 
such as TOP, TOPO, and quinoline.[113a,121] Dehalosilyla-
tion reactions resulted in appropriate control over the sizes to 
yield highly crystalline QDs at lower temperatures and shorter 
times.[122]
GaN is a classic group III–V QD with a wide and direct 
band,[123] containing 3.2–3.3 eV for zinc blende bulk GaN 
at room temperature, which is important for UV optoelec-
tronics.[124] GaN semiconductors possess excellent thermal, 
chemical, optical properties, and radiation stability; there-
fore, have the potential to be used for applications in 
current-injected laser diodes (LDs) and LEDs. Due to a lack 
of appropriate N-precursors, the synthesis of solution-based 
GaN QDs was mostly focused on two reactions: metathetical 
reaction and thermolysis. The metathetical reaction, followed 
under solvothermal conditions, has been recognized as a fea-
sible wet-chemical approach for GaN QD synthesis.[123,125] 
However, despite the low reaction temperature and acceptable 
diameter control, poor solubility of QDs may lead to aggrega-
tion. Hence, capping agents such as TOPO seldom have been 
utilized for the GaN QD synthesis.[126] Additionally, thermolysis 
reactions, through precursor decomposition at a moderately 
low temperature, were also employed for the GaN nanoparticle 
synthesis. In this reaction, single source precursors containing 
Ga and N with an existing Ga-N bond in a single molecule were 
utilized.[124,127] To control growth and inhibit agglomeration, 
different types of amines such as N, N, N, N-tetramethyl-1 and 
6-hexanediamine (TMHDA) were investigated as surfactant/
capping agent, where blue-color photoluminescent Ga-N QDs 
were achieved through pyrolysis of gallium imide by boiling 
TMHDA.[127c]
Among the Ga-based III–V semiconductor, GaAs possesses 
a wide variety of properties and has demonstrated the poten-
tial to be used for different applications such as modern opto-
electronic devices and solar cells.[128] In metal organic chemical 
vapour deposition strategy, uniform structures of GaAs, even 
without crystal defects, can be achieved. However, this high-
quality strategy of QD synthesis requires highly toxic precur-
sors such as arsine or pyrophoric materials. Therefore, finding 
an alternative less toxic and more cost effective wet-chemical 
synthesis method has recently received significant attention.[117]
A typical wet-chemical synthesis method of GaAs QDs has 
been reported by Wells et al., which utilized a dehalosylation 
reaction between gallium salt and [As(TMSi)3].[120] The solvent 
and precursors played a key role in the morphology, size dis-
tribution, and purity of the GaAs QDs synthesized by using a 
dehalosylation reaction. It was reported that GaAs QDs with 
a narrow size distribution were obtained through a reaction 
between GaCl3 and [As(NMe2)3] in 4-ethylpyridine as a coordi-
nating solvent.[129] Moreover, a novel and simple synthesis of 
colloidal GaAs nanocrystals based on a transmetalation reaction 
has been reported.[117] Transmetalation reactions are a class of 
organometallic reaction where the transfer of organic groups/
ligands from one metal to another occurs. This reaction is the 
underlying principle for preparing various organo-transition 
metal complexes. Mechanistically, in transmetalation organic 
group or neutral ligand is transferred from main group metal 
to transition metal.[130] This wet chemical approach could pro-
duce highly crystalline nanomaterials and was shown to yield a 
narrow size distribution by using reagents with reduced toxicity. 
Transmetalation of gallium (III) halides with n-butyllithium 
resulted in producing the elemental gallium. Subsequently, 
GaAs nanocrystals could be achieved by reaction between the 
elemental gallium species and Mg3As2.[117]
InP QDs can also be considered an effective candidate to 
replace or even surpass CdSe nanocrystals in some applica-
tions such as bio-imaging and photodynamic therapy.[131] InP 
nanocrystals can provide comparable or even preferable emis-
sion color to that of CdSe QDs. Notably, unlike cadmium, sele-
nium, or arsenic, it has been demonstrated that InP possesses 
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low intrinsic toxicity. InP nanocrystals are also structurally 
stable, leading to a better optical stability in biological sys-
tems.[132] The synthesis of InP QDs has been further investi-
gated in comparison with that for other III–V QDs.[133] Recent 
investigations report that InP QDs have been fabricated 
by means of thermolysis of InP-precursor in a hot mixture 
containing TOPO and TOP.[113a,b] Although it was shown that a 
dehalosilylation reaction can be utilized for InP QD synthesis, 
owing to the high reactivity of the phosphorous precursor 
such as [P(TMS)3], this reaction is difficult to maintain due to 
the ultrarapid nucleation, consuming almost all phosphorous 
precursor.[133,134] Moreover, the uncontrolled mechanism of 
nucleation leads to the formation of poor size distributions.[135] 
Classically, a number of indium halides were used as precur-
sors and TOP served as a solvent, stabilizing agent, and phos-
phorus source.[117] To maintain the reaction under control, 
carboxylate ligands have been used instead of phosphorous 
precursors, such as phosphine, to reduce the speed of nuclea-
tion. In this strategy, the reduced nucleation allowed for leaving 
some unreacted precursor for postnucleation growth which led 
to the production of narrowly sized InP QDs.[135]
9.2. Liquid-Solid-Solution (LSS) Phase Transfer Process
Synthesis of a wide variety of narrow disperse QDs with dif-
ferent chemistries was introduced by Li et al. through LSS 
phase transfer based on ion exchange.[136] This approach is 
based on the gradual transfer of the reactants from one phase 
to another as the reaction progresses, where “general phase 
transfer” and “phase separation” phenomena occur. Thus, 
there are three different phases in which separate reactions 
progress, and at the same time, the reactions occur among the 
reactants from different phases. In the solid phase, sodium 
linoleate is present, whereas, in liquid phase ethanol and lin-
oleic are present. In addition, there is a solution phase of water-
ethanol containing metal ions. First, metal ions are reduced 
by ethanol at the interfaces of liquid or solution phases at dif-
ferent temperatures from 20 to 200 °C and at the same time 
metal-linoleate is conjugated with hydrophobic surfaces in a 
phase transfer reaction (Figure 12). Finally, due to the weight of 
nanocrystal and also an incompatibility between hydrophobic 
surfaces of metals and surrounding hydrophilic nature, phase 
separation can occur and nanocrystals can be simply collected. 
To yield compounds, such as TiO2, CuO, ZrO2, SnO2, or ZnO, 
the metal ions dehydrate into oxides in designed reaction cir-
cumstances. Alternatively, there is a possibility that metal ions 
react with anion species such as S2−, or Se2− to form molecules, 
such as ZnS or ZnSe. Using this method, the size of QDs can 
be affected by various factors such as temperature, mole ratio, 
and the length of alkyl chains.[136]
9.3. Top-Down and Bottom-Up Approaches
QD may be synthesized using either a top-down or bottom-
up technique. Generally, in the top-down approaches, such 
as electron beam lithography and reactive-ion etching, a bulk 
semiconductor is mixed with water to form QDs.[2a] In contrast, 
bottom-up or self-assembly techniques may be generally sub-
divided into wet-chemical and vapour-phase 
methods.[137]
Generally, top-down strategies include 
techniques such as lithography-based tech-
nique,[138] electrochemical synthesis[139] acidic 
oxidation-based synthesis,[140] hydrothermal/
solvothermal synthesis,[141] and microwave-
assisted synthesis.[142] In contrast, bottom-up 
strategies include methods such as oxidative 
condensation reactions,[143] self-assembly 
synthesis of graphene quantum dots (GQDs) 
based on using hexa-perihexabenzocoro-
nene as a precursor,[144] and using benzene 
derivatives.[143b]
In wet-chemical approaches such 
as microemulsion,[87,145] hot-solution 
decomposition[44a,71,73] and sonic waves 
or microwaves,[146] the conventional 
precipitation procedures are involved, in 
which there is strict control over solutions 
parameters. The nucleation and limited 
growth of nanoparticles are two main fea-
tures of the precipitation stage. However, 
the nucleation process can be homogenous, 
heterogeneous or secondary types.[126] In 
the vapour-phase method, the thermody-
namically unstable vapour phase mixtures 
produce nanoparticles.[147] The vapour-phase 
synthesis and passivation of luminescent 
Part. Part. Syst. Charact. 2019, 36, 1800302
Figure 12. Nanocrystal synthesis based on liquid-solid-solution phase transfer strategy. In this 
approach, the reactants, which are presented in different phases, are transferred to different 
phase as the reaction progresses. Adapted with permission.[136] Copyright 2005, Nature 
Publishing Group.
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ZnSe nanocrystals have been also reported.[148] This synthesis 
method of group II–VI QDs demonstrated better compat-
ibility with current operations in the microelectronics industry 
compared with traditional liquid-phase techniques. Using wet-
chemical synthesis methods, a thiol-based passivation process 
could lead to the well-stable photoluminescence properties 
of QDs, while the nucleation remained unaffected. This indi-
cates that thiolation can be a suitable passivation method for 
increasing the quality of the resultant QDs.
Moreover, it is reported that Si substrates can be decorated 
by using extreme ultraviolet interference lithography tech-
nique, 2D hole arrays (2DHAs), and reactive ion etching.[149] 
3D well-organized SiGe QDs and 3D QDs arrays (crystals) 
decorated on Si substrates have been fabricated with extraor-
dinary structural perfection.[149] Both conventional top-down 
lithographic techniques and bottom-up methods have been 
widely utilized to develop QDs. However, the growth of self-
assembled QDs applied on planar substrates has resulted 
in random nucleation and relatively broad size distribution. 
Nonetheless, within the past decade, to avoid basic issues 
originated from random nucleation, self-assembly pattern 
of semiconductor nanostructures has attracted extensive 
attention.[149]
9.4. Graphene QD Synthesis
GQDs are deemed 0D materials, which possess the beneficial 
characteristics of both graphene and carbon dots (CDs).[150] 
GQDs have unique properties including good photostability 
against photobleaching and blinking, and lower toxicity in com-
parison with semi-conductive nanocrystals, as well as organic 
fluorophores.[151] In recent years, this new class of nanomate-
rials has drawn great attention in biomedical field.[152]
Synthesis of GQDs can be categorized into the top-down 
and bottom-up approaches. In top-down strategies, carbon-
derived products such as carbon fibers, graphite or graphene 
sheets, and carbon nanotubes are cut into nanoparticles. In 
the bottom-up methods, by contrast, precursors are used to 
produce GQDs.[154] In 2010, blue photoluminescent (PL) GQDs 
were synthesized through the hydrothermal cutting of oxidized 
graphene sheets resulting in GQDs with sub-10 nm sizes, with 
a quantum yield of 6.9%.[153] Moreover, direct electrochemical 
synthesis of green-luminescent GQDs, ranging from 3–5 nm, 
was reported.[154] In this study, filtration-formed graphene film 
was used as a working electrode and the reaction was carried 
out in phosphate buffered saline.
More recently, Chua et al.[155] reported a novel method 
based on top-down wet chemistry approach for the production 
of GQDs (Figure 13). In this method, fullerene C60 or buck-
minsterfullerene, as a spherical molecule with fused hex-
agonal and pentagonal structures, was treated with a mixture 
of strong acid and chemical oxidant inducing oxidation and 
cage-opening processes (Hummers method). The prepared 
QDs, with a diameter of ≈1 nm, exhibited the highest lumi-
nescence intensity at 460 nm under a 340 nm excitation wave-
length. This strategy, due to its simplicity, can be considered 
for further improvements to integrate into optoelectronics-
based devices.
10. Prospective Biomedical Applications of QDs
Nanotechnology is widely being applied in different industrial 
fields. Nanomaterials could have a game-changing role in non-
biomedical applications such as displays. The majority of these 
nanomaterials have modified in a way to represent the quality 
expected for a nonbiomedical application. However, this quality 
Figure 13. The general properties of GQDs. A) Synthesis of GQDs via oxidation and cage-opening of fullerene C60 induced by strong acid. B) Evaluation 
of GQDs optical properties: GQDs excited at 405 nm by a blue laser pointer. Reproduced with permission.[155] Copyright 2015, American Chemical Society.
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makes them inappropriate for biomedical applications mainly 
due to their toxic effects and their incompatibility in biosys-
tems. For example, a disappointing rate of only 0.7% of the 
administered nanoparticle dose could be delivered to a solid 
tumor.[156] Consequently, the success rate of nanotechnology in 
the clinical translation of nanomaterials has been limited.
The reasons for the limited application of nanomaterials 
in biomedical applications are diverse. However, lack of deep 
understanding of nano–bio interfaces could be highlighted 
as one of the main reasons. To address this issue, three main 
factors should be deeply addressed including: i) the nano 
parame ters, ii) the complexity of biological systems, and iii) the 
interactions between nano and bio-parameters.[157] The lack of 
deep studies in terms of the interactions between these three 
factors has made a considerable inconsistency in nanomedicine 
data which causes misinterpretations of the current literature 
and subsequently, poor control over the desired application in 
the clinical translation of nanoparticles. Therefore, for successful 
applications of nanomaterials including QDs in a biological con-
text, these three parameters should be optimized appropriately.
QDs show potential as materials to be utilized in three 
main areas of biological-related applications: imaging,[158] 
biosensing,[159] and therapeutic applications.[160] Multicolor 
imaging with QDs typically involves the specific binding of QDs 
to analytes such as genes and antibodies for cells staining,[161] 
animal imaging,[162] and tumor biology investigation.[163] QD-
labeled DNA probes[24a,164] and antibody molecules[165] are used 
for targeted detection of nucleic acids and proteins. These 
fluorescent nanobiostructures are considered the principal 
components of novel QDs-based optical and electrochemical 
biosensors. QDs have been used as therapeutic agents in 
photodynamic therapy[166] as treatments for a number of malig-
nancies and also drug delivery systems.[167] One of the emerging 
applications of QD-based nanomaterials is theranostic applica-
tions where the optical properties and the surface chemistry 
of QDs play a central role in the simultaneous diagnosis and 
therapy of diseases such as cancer.[74,76] Also, QDs are being 
used as a signal enhancer to improve the specificity of molec-
ular techniques.[168]
Depending on specific physicochemical properties origi-
nated from the synthesis route and the surface modifications, 
different types of QDs can find specific applications. In terms 
of biocompatibility, some synthesis routes offer QDs with 
minimal environmental and biological toxicity. Thus, these 
QDs can be used in the environmental analysis and in vivo 
biosystems. The application of QDs can be also affected by the 
complexity and the cost of their synthesis as well as their fluo-
rescent stability and electrical properties.
Among the different types of QDs, GQDs possess character-
istics required for materials used for biomedical applications, 
including excellent biocompatibility as well as low-cost and 
ease of synthesis. One study reported the use of GQDs as a 
fluorescence resonance energy transfer (FRET)-based tracer of 
protease activity in the real clinical samples due to their bio-
compatibility and stable photoluminescence.[152a] Also, their 
excellent electrical properties allow their use in electrochemical-
based nanobiosensors.[152b]
Surface engineering of GQDs opens a new window for fur-
ther applications in the nanobiosensing field. For instance, 
tyramine-functionalized GQDs have been utilized by 
Li N et al.[152c] to profile a range of metabolites as biomarkers 
for human diseases. Upon exposure to the GQDs, these metab-
olites induce a tyramine-mediated crosslinking of GQDs that 
leads to the quenching of their fluorescence.
Replacing the less-stable shell of CdSe QD systems with a 
more chemically stable shell allowed for the development of 
l InAs (ZnCdS) QDs where the surface may be readily func-
tionalized. This, in turn, led to designing a new generation of 
QDs that can be traced using the near-infrared (NIR) spectrum. 
Application of these NIR-responsive QDs in vivo significantly 
improved the resolution of images obtained from veins.[169] A 
novel in vivo imaging modalities has also been designed with 
the capability of real-time and high-resolution spatial imaging 
of cancer, neurological, and metabolic diseases.[170] As the syn-
thesis and surface engineering methods continue to evolve, 
QD-based nanomaterials demonstrate improved performance 
for use in biomedical applications.
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